Insulet tops S&P 500 growth chart for Q2 as it gains market share in the diabetes space
2024-06-29
The Health Care Select Sector SPDR Fund ETF (NYSEARCA:XLV), tracking the healthcare companies under S&P 500, rose 0.11% in the second quarter of 2024, lagging behind the broader S&P 500 index which rose 4.30%. Insulet (PODD) saw the biggest growth in the S&P 500 healthcare index, rising about 25% asContinue Reading